Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma MFM

What's the purpose of this trial?

The purpose of this project is to evaluate the impact of a 16-week lifestyle program that promotes changes in eating and exercise patterns. The main questions the study will answer are: Do improvements in eating and exercise patterns lead to improved physical function, quality of life and blood biomarkers of biologial aging among individuals with multiple myeloma? Participants will complete study activities 3-4 times during the study. 1. In-person assessment to measure physical function, height/weight, body composition, and includes a blood draw 2. Surveys completed online or on paper at home

This trial is currently open and accepting patients.

What will happen during the trial?

You may be able to join this trial if you:

The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required.

Inclusion Criteria:

  1. Adult (≥ 18 years)
  2. Diagnosed with MM at least one year prior to study enrollment
  3. 100 days post transplant (if applicable)
  4. Has access to a smart phone or device with internet access

  5. Be deemed "clinically stable" by their physician guided by the following:

    1. not expected to receive therapies beyond maintenance (for 100 days)
    2. no new significant myeloma symptoms (e.g., fractures, spinal stability concerns) meriting changes in anti-neoplastic therapies in the next 30 days; AND
    3. stable performance status (ECOG 0-2) assessed in the last 3 months
  6. No reports of severe pain > Grade 3 [defined by the NCI CTCAE as tumor, neurologic, bone, or other pain interfering with self-care ADLs (bathing, dressing, toileting, continence, feeding)].
  7. Able to participate in PA and strength training per clinician approval and confirmed by participant
  8. Able to understand and willing to sign a written informed consent document
  9. English proficient for reading and writing

Exclusion Criteria:

  1. Coexistent amyloidosis, POEMS syndrome will not be approached
  2. Fully adherent to the ACS nutrition and physical activity guidelines
  3. If participant is of child-bearing age they cannot be pregnant, planning to come pregnant or lactating during the study period
  4. On another interventional clinical trial that precludes co-enrollment
  5. Psychiatric or other clinical conditions that preclude study compliance
  6. Other important medical or safety considerations at the discretion of the investigator(s) and/or approving clinician

Additional Trial Information

Enrollment: 184 patients (estimated)

View More
Need Help?

Interested in joining or learning more about this trial?

(888) 828-2206

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.

Illinois

Loyola University Medical Center Cardinal Bernardin Cancer Center

Maywood, IL

Open and Accepting

Wisconsin

Medical College of Wisconsin Froedtert Hospital

Milwaukee, WI

Open and Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • Add this trial to your favorites keyboard_arrow_right

    If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message